Our Insights
Our insights
As access experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the latest expanded access activity and insights.
Uniphar to run pan-European Managed Access Program for new epilepsy drug
COVID-19 is no obstacle to Expanded Access
Marinus Pharmaceuticals initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV
TFF Pharmaceuticals and Uniphar announce EAP for voriconazole inhalation powder
SIFI and Uniphar announce the opening of an Early Access Program for Akantior
